loadpatents
name:-0.06647777557373
name:-0.051524877548218
name:-0.022316932678223
Frank-Kamenetsky; Maria Patent Filings

Frank-Kamenetsky; Maria

Patent Applications and Registrations

Patent applications and USPTO patent grants for Frank-Kamenetsky; Maria.The latest application filed is for "angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof".

Company Profile
14.33.51
  • Frank-Kamenetsky; Maria - Brookline MA
  • Frank-Kamenetsky; Maria - Brookling MA
  • Frank-Kamenetsky; Maria - Cambridge MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20220235358 - Bettencourt; Brian ;   et al.
2022-07-28
DUAL TARGETING siRNA AGENTS
App 20220213475 - Fitzgerald; Kevin ;   et al.
2022-07-07
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant 11,332,743 - Bettencourt , et al. May 17, 2
2022-05-17
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant 11,306,315 - Bettencourt , et al. April 19, 2
2022-04-19
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant 11,306,314 - Bettencourt , et al. April 19, 2
2022-04-19
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant 11,306,316 - Bettencourt , et al. April 19, 2
2022-04-19
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20220073925 - Bettencourt; Brian ;   et al.
2022-03-10
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20220073929 - Bettencourt; Brian ;   et al.
2022-03-10
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20220073926 - Bettencourt; Brian ;   et al.
2022-03-10
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20220073924 - Bettencourt; Brian ;   et al.
2022-03-10
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20220073927 - Bettencourt; Brian ;   et al.
2022-03-10
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20220073928 - Bettencourt; Brian ;   et al.
2022-03-10
Compositions And Methods For Inhibiting Expression Of The Pcsk9 Gene
App 20210403917 - Tan; Pamela ;   et al.
2021-12-30
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant 11,130,953 - Bettencourt , et al. September 28, 2
2021-09-28
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210171954 - Bettencourt; Brian ;   et al.
2021-06-10
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210171955 - Bettencourt; Brian ;   et al.
2021-06-10
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant 10,934,545 - Bettencourt , et al. March 2, 2
2021-03-02
Dual Targeting siRNA Agents
App 20200332292 - Fitzgerald; Kevin ;   et al.
2020-10-22
Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
App 20200318119 - Tan; Pamela ;   et al.
2020-10-08
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200140866 - Bettencourt; Brian ;   et al.
2020-05-07
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant 10,557,139 - Bettencourt , et al. Feb
2020-02-11
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant 10,550,390 - Bettencourt , et al. Fe
2020-02-04
Compositions and methods for inhibiting expression of the PCSK9 gene
Grant 10,501,742 - Tan , et al. Dec
2019-12-10
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20190352645 - Bettencourt; Brian ;   et al.
2019-11-21
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20190316137 - Bettencourt; Brian ;   et al.
2019-10-17
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant 10,337,010 - Bettencourt , et al.
2019-07-02
METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA
App 20190153443 - Fitzgerald; Kevin ;   et al.
2019-05-23
PCSK9 iRNA compositions and methods of use thereof
Grant 10,125,369 - Borodovsky , et al. November 13, 2
2018-11-13
Methods for increasing efficacy of lipid formulated siRNA
Grant 10,053,689 - Fitzgerald , et al. August 21, 2
2018-08-21
Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
App 20180216115 - Tan; Pamela ;   et al.
2018-08-02
Dual Targeting siRNA Agents
App 20180148722 - Fitzgerald; Kevin ;   et al.
2018-05-31
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20170355994 - Bettencourt; Brian ;   et al.
2017-12-14
Compositions and methods for inhibiting expression of the PCSK9 gene
Grant 9,822,365 - Tan , et al. November 21, 2
2017-11-21
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant 9,771,591 - Bettencourt , et al. September 26, 2
2017-09-26
Compositions and Methods for Inhibition of PCSK9 Genes
App 20160354404 - Hinkle; Gregory ;   et al.
2016-12-08
Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
App 20160348117 - Tan; Pamela ;   et al.
2016-12-01
Dual Targeting siRNA Agents
App 20160312216 - Fitzgerald; Kevin ;   et al.
2016-10-27
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20160186180 - Bettencourt; Brian ;   et al.
2016-06-30
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant 9,322,018 - Bettencourt , et al. April 26, 2
2016-04-26
Compositions and methods for inhibiting expression of the PCSK9 gene
Grant 9,260,718 - Tan , et al. February 16, 2
2016-02-16
METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA
App 20160024498 - Fitzgerald; Kevin ;   et al.
2016-01-28
PCSK9 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20160017335 - Borodovsky; Anna ;   et al.
2016-01-21
Dual targeting siRNA agents
Grant 9,187,746 - Fitzgerald , et al. November 17, 2
2015-11-17
Methods for increasing efficacy of lipid formulated siRNA
Grant 9,051,567 - Fitzgerald , et al. June 9, 2
2015-06-09
iRNA Agents Targeting VEGF
App 20150011608 - de Fougerolles; Antonin ;   et al.
2015-01-08
Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
App 20140350075 - Tan; Pamela ;   et al.
2014-11-27
Small organic molecule regulators of cell proliferation
Grant 8,852,937 - Baxter , et al. October 7, 2
2014-10-07
Compositions and methods for inhibiting expression of the PCSK9 gene
Grant 8,809,292 - Tan , et al. August 19, 2
2014-08-19
ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20140179768 - Bettencourt; Brian ;   et al.
2014-06-26
Compositions And Methods For Inhibiting Expression Of The PCSK9 Gene
App 20130331430 - Tan; Pamela ;   et al.
2013-12-12
Compositions and Methods for Inhibition of PCSK9 Genes
App 20130289094 - Hinkle; Gregory ;   et al.
2013-10-31
Dual Targeting siRNA Agents
App 20130184324 - Fitzgerald; Kevin ;   et al.
2013-07-18
iRNA Agents Targeting VEGF
App 20130018085 - de Fougerolles; Antonin ;   et al.
2013-01-17
iRNA agents targeting VEGF
Grant 8,293,719 - De Fougerolles , et al. October 23, 2
2012-10-23
Methods For Increasing Efficacy of Lipid Formulated siRNA
App 20120244207 - Fitzgerald; Kevin ;   et al.
2012-09-27
Compositions and methods for inhibiting expression of the PCSK9 gene
Grant 8,222,222 - Tan , et al. July 17, 2
2012-07-17
Small organic molecule regulators of cell proliferation
Grant 8,129,425 - Baxter , et al. March 6, 2
2012-03-06
Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
App 20110230542 - Tan; Pamela ;   et al.
2011-09-22
iRNA Agents Targeting VEGF
App 20110224282 - De Fougerolles; Antonin ;   et al.
2011-09-15
PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS
App 20110218334 - Maier; Martin ;   et al.
2011-09-08
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE
App 20110124711 - Sah; Dinah ;   et al.
2011-05-26
iRNA agents targeting VEGF
Grant 7,947,659 - de Fougerolles , et al. May 24, 2
2011-05-24
IRNA agents targeting VEGF
Grant 7,919,473 - De Fougerolles , et al. April 5, 2
2011-04-05
Compositions and methods for inhibiting expression of Nav1.8 gene
Grant 7,902,168 - Sah , et al. March 8, 2
2011-03-08
Compositions and methods for inhibiting expression of the PCSK9 gene
Grant 7,605,251 - Tan , et al. October 20, 2
2009-10-20
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE
App 20090258934 - Sah; Dinah ;   et al.
2009-10-15
Compositions and methods for inhibiting expression of Nav1.8 gene
Grant 7,582,745 - Sah , et al. September 1, 2
2009-09-01
Small organic molecule regulators of cell proliferation
App 20080207740 - Baxter; Anthony David ;   et al.
2008-08-28
Compositions And Methods For Inhibiting Expression Of The Pcsk9 Gene
App 20080113930 - Tan; Pamela ;   et al.
2008-05-15
Compositions and methods for inhibiting expression of Nav1.8 gene
App 20070105806 - Sah; Dinah ;   et al.
2007-05-10
Small organic molecule regulators of cell proliferation
App 20060287385 - Baxter; Anthony David ;   et al.
2006-12-21
IRNA agents targeting VEGF
App 20060223770 - Fougerolles; Antonin De ;   et al.
2006-10-05
Small organic molecule regulators of cell proliferation
Grant 7,115,653 - Baxter , et al. October 3, 2
2006-10-03
iRNA agents targeting VEGF
App 20060094032 - Fougerolles; Antonin De ;   et al.
2006-05-04
Small organic molecule regulators of cell proliferation
App 20050070578 - Baxter, Anthony David ;   et al.
2005-03-31
Small organic molecule regulators of cell proliferation
App 20030139457 - Baxter, Anthony David ;   et al.
2003-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed